Intellectual Property in the Field of Regenerative Medicine in Japan

Shigehiro Asano, Yoichi Nakanishi, Daisuke Sugiyama

Research output: Contribution to journalArticle

2 Citations (Scopus)


Purpose: Although most pharmaceutical companies and bio-ventures have not yet created a practical business model or a credible exit thus far, most are expecting potential new business to be derived from regenerative medicine. This article discusses and proposes some ideas regarding a patent strategy for regenerative medicine. Methods: PubMed literature searches were conducted to identify recent reports relevant to regenerative medicine. Information regarding patents and patent applications were obtained from the database service of the Japan Platform for Patent Information on the website of the National Center for Industrial Property Information and Training at and the Japan Patent Office at Findings: The infrastructure of regenerative medicine in Japan is still maturing. Patent protection is important in regenerative medicine considering its special characteristics. Implications: Based on the understanding of the special characteristics of regenerative medicine, this article discusses and proposes some ideas regarding a patent strategy for the field, which is different from that of a typical patent strategy as in the case of a small-molecule drug.

Original languageEnglish
Pages (from-to)1823-1827
Number of pages5
JournalClinical Therapeutics
Issue number11
Publication statusPublished - Nov 2018


All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this